Playlist

Turkmenistan Bestows Honorary Titles on Leading Specialists in the Equine Industry

24 Apr. 04:00

Source

On the occasion of the National Feast of the Turkmen Steed, the President of Turkmenistan signed a decree awarding the honorary title of "Honored Horse Breeder of Turkmenistan" to several distinguished citizens. The decree recognizes their exceptional contributions to promoting the global prestige of Akhal-Teke horses and their dedicated efforts in preserving the pedigree and unique characteristics of this world-renowned breed. This state recognition highlights the importance of the equine sector as a cornerstone of national heritage and economic pride.

The recipients of these prestigious awards include both public sector employees from international equestrian complexes and independent private breeders. This inclusive approach demonstrates the state's commitment to supporting diverse professional activities aimed at modernizing the industry. The awarded individuals have demonstrated exemplary skill and long-term commitment to advancing equine production standards and ensuring the sustainability of traditional breeding methods.

The distribution of the titles across various regions, including the capital Ashgabat as well as the Balkan and Dashoguz provinces, reflects the widespread nature of the country's horse-breeding infrastructure. Each awardee has played a pivotal role in maintaining the biological purity and aesthetic excellence of the "heavenly horses." Their work is instrumental in fostering international partnerships and showcasing the nation's expertise in specialized animal husbandry.

Such high-level official recognition serves as an incentive for current and future generations of specialists to maintain the highest standards of professional excellence. The enhancement of the domestic equine industry remains a strategic priority, focusing on both cultural preservation and the promotion of equestrian sports. This presidential decree reinforces the systematic support provided to those who ensure the continuous development of Turkmenistan's elite equine traditions.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds

Today in 02:02

Source

Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.

Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌